Ladarixin
Ladarixin (DF 2156A free base) is an orally active, non-competitive CXCR1/CXCR2 allosteric inhibitor that suppresses AKT, NF-κB, and angiogenesis, thereby slowing the progression of experimental human melanoma. It may be employed in research concerning COPD, asthma, and melanoma.
Product Specifications
CAS Number
849776-05-2
Field of Research
Cell Biology, Immunology & Inflammation, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.36% (May vary between batches)
Smiles
C[C@@H] (C (=O) NS (C) (=O) =O) c1ccc (OS (=O) (=O) C (F) (F) F) cc1
Molecular Formula
C11H12F3NO6S2
Molecular Weight
375.34
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
49152065 1.0 µg DNA
Uhrf1 Lentiviral Vector (Mouse) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details SR320702 1 Kit
Integrin alpha 5 (ITGA5) Human siRNA Oligo Duplex (Locus ID 3678)
Sign In for Pricing
View Details 
VAng-Lsx4047-50gEcoli 50 µg (E. coli)
Recombinant Bordetella Avium gcvT Protein (aa 1-366)
Sign In for Pricing
View Details